Evidence map›Paper›PMID 34347623›Full record

ArticleAging2021

The role of age at menarche and age at menopause in Alzheimer's disease: evidence from a bidirectional mendelian randomization study.

Mingli Li, Jiali Lin, Shuang Liang, Zefeng Chen, Yulan Bai, Xinyang Long, Shengzhu Huang, Zengnan Mo

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Among men, androgens are associated with a decrease in Alzheimer's disease risk.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mingli LiCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, Guangxi, China.
Jiali LinCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, Guangxi, China.
Shuang LiangCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, Guangxi, China.
Zefeng ChenCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, Guangxi, China.
Yulan BaiCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, Guangxi, China.
Xinyang LongCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, Guangxi, China.
Shengzhu HuangCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, Guangxi, China.
Zengnan MoCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, Guangxi, China.
Guangxi University · CNGuangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The association between endogenous estrogen exposure and Alzheimer's disease (AD) remains inconclusive in previous observational studies, and few Mendelian randomization (MR) studies have focused on their causality thus far. We performed a bidirectional MR study to clarify the causality and causal direction of age at menarche and age at menopause, which are indicators of endogenous estrogen exposure, on AD risk. We obtained all genetic datasets for the MR analyses using publicly available summary statistics based on individuals of European ancestry from the IEU GWAS database. The MR analyses indicated no significant causal relationship between the genetically determined age at menarche (outlier-adjusted inverse variance weighted odds ratio [IVWOR] = 0.926; 95% confidence interval [CI], 0.803-1.066) or age at menopause (outlier-adjusted IVWOR = 0.981; 95% CI, 0.941-1.022) and AD risk. Similarly, AD did not show any causal association with age at menarche or age at menopause. The sensitivity analyses yielded similar results. In contrast, an inverse association was detected between age at menarche and body mass index (BMI, outlier-adjusted IVW β = -0.043; 95% CI, -0.077 to -0.009). Our bidirectional MR study provides no evidence for a causal relationship between the genetically determined age at menarche or age at menopause and AD susceptibility, or vice versa. However, earlier menarche might be associated with higher adult BMI.

Indexed as

Age FactorsAlzheimer DiseaseBody Mass IndexFemaleGenetic VariationGenome-Wide Association StudyHumansMenarcheMendelian Randomization AnalysisMenopauseage at menarcheage at menopauseAlzheimer's diseasemendelian randomization study

Identifiers

PMID34347623
PMCPMC8386554
OpenAlexW3189115666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.